Charles River (NYSE: CRL) director exercises options, sells 573 shares
Rhea-AI Filing Summary
For CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), director Nancy C. Andrews reported an option exercise and same-day sale. She exercised 573 stock options at an exercise price of $164.30 per share, acquiring 573 shares of common stock, and then sold 573 common shares at $285.24 per share. After these transactions, she reported 3,964 common shares held indirectly by trust. The Rule 10b5-1 trading-plan box was not checked.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 573 shares ($69K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Andrews Nancy C
Role
Director
Sold
573 shs ($163K)
Approx. gross sale proceeds
$163K
Approx. exercise cost
$94K
Approx. pre-tax spread
$69K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 573 | $0.00 | $0.00 |
| Exercise | Common Stock | 573 | $164.30 | $94K |
| Sale | Common Stock | 573 | $285.24 | $163K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 0 shares (Direct);
Common Stock — 1,438 shares (Direct);
Common Stock — 3,964 shares (Indirect, By Trust)
Key Figures
Options exercised: 573 shares
Option exercise price: $164.30 per share
Common shares sold: 573 shares
+4 more
7 metrics
Options exercised
573 shares
Stock options (right to buy) exercised into common stock
Option exercise price
$164.30 per share
Exercise price for 573 stock options
Common shares sold
573 shares
Common stock sold following option exercise
Sale price
$285.24 per share
Price for sale of 573 common shares
Indirect holdings after transaction
3,964 shares
Common stock held indirectly by trust after reported transactions
Option expiration date
2027-03-02
Expiration date of exercised stock options
Option grant exercise date
2021-03-02
Exercise date field for the derivative security
Key Terms
Stock Options (Right to Buy), Exercise or conversion of derivative security, indirect, By Trust, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
indirect financial
"ownership_type: indirect, nature_of_ownership: By Trust"
By Trust financial
"nature_of_ownership: By Trust"
Rule 10b5-1 regulatory
"Rule 10b5-1 trading-plan box was not checked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did Nancy C. Andrews report for CRL on this Form 4?
Nancy C. Andrews reported exercising 573 stock options for Charles River Laboratories (CRL) at $164.30 per share and acquiring 573 common shares, then selling all 573 shares at $285.24 per share on the same date.
What was the exercise price of the stock options reported by Nancy C. Andrews for CRL?
The stock options exercised by Nancy C. Andrews for Charles River Laboratories (CRL) had an exercise price of $164.30 per share, with 573 options exercised into an equal number of common shares.
Was the CRL insider transaction made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox was not checked, indicating the reported transactions were not affirmed as being made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
